Objective: This study was aimed to determine the seroprevalence profiles and
seroprotection for pertussis and diphtheria among adult. Methods: A cross-sectional …

Objective To learn the immunity levels of pertussis and diphtheria among healthy people in
Wenzhou City, and to provide scientific evidence for the effective control of the two diseases …

In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccines were licensed and recommended for use in adults and adolescents in the United …

▪ Persons aged (7–18 years and≥ 19 years) who have never been vaccinated against
pertussis, tetanus, or diphtheria should receive a series of three tetanus and diphtheria …

Patients with chronic diseases are at increased risk of complications following infection. It
remains, however, unknown to what extend they are protected against vaccine-preventable …

There is increasing interest in prevention of pertussis in adults by vaccination, but little is
known about the duration of the antibody response to pertussis, diphtheria or tetanus in …

This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

The duration of protection after vaccination with reduced antigen content diphtheria, tetanus
and acellular pertussis vaccines (Tdap) is not known. Long-term post-vaccination …

OBJECTIVES: Despite extensive childhood immunization, pertussis remains one of the
world's leading causes of vaccine-preventable deaths. Incidence of pertussis in adolescents …

Background. Pertussis is among the most poorly controlled bacterial vaccine-preventable
diseases in the United States. In 2006, a tetanus, reduced-dose diphtheria, and acellular …